Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-05

FDA Approved: BUMETANIDE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approves the original application for bumetanide (generic) from Novadoz Pharmaceuticals LLC, a loop diuretic indicated for edema associated with congestive …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUMETANIDE (bumetanide)

Snippet

ORIG AP for BUMETANIDE (BUMETANIDE)